Z-1161-2013 Class III Terminated

Recalled by Ortho-Clinical Diagnostics — Rochester, NY

FDA device recall Z-1161-2013 was initiated by Ortho-Clinical Diagnostics on Nov 1, 2012 and is designated Class III. Reason for recall: Ortho Clinical Diagnostics is recalling certain lots of the Vitros Anti-HBs Reagent packs an inability to obtain a valid calibration. The recall status is terminated (terminated Mar 30, 2017). Affected quantity: 1464 units.

Recall details

Product Type
Devices
Report Date
May 1, 2013
Initiation Date
Nov 1, 2012
Termination Date
Mar 30, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1464 units

Product description

VITROS¿ Immunodiagnostic Products Anti-HBs (total antibody to hepatitis B surface antigen (anti-HBs)) Reagent Packs For the quantitative in vitro determination of total antibody to hepatitis B surface antigen (anti-HBs) in human serum.

Reason for recall

Ortho Clinical Diagnostics is recalling certain lots of the Vitros Anti-HBs Reagent packs an inability to obtain a valid calibration.

Distribution pattern

Worldwide Distribution- USA (nationwided) and countries of: Australia, Brazil, Canada, Chile, Chao Yang District, Beijing, Columbia, England, France, Germany, India, Italy, Japan, Mexico, Republic of Panama, Singapore, Spain and Venezuela.

Code information

Lot #'s 6630 expiration 2/26/2013, Lot # 6740 expiration 6/18/2013 and Lot # 6750 expiration date 6/11/2013.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1161-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1161-2013. Report a data issue: hello@regdatalab.com.